{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:04Z","timestamp":1761518884733,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.jocd.2008.07.003","type":"journal-article","created":{"date-parts":[[2008,8,31]],"date-time":"2008-08-31T05:38:31Z","timestamp":1220161111000},"page":"478-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Clinician's Perspective on the Use of Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis"],"prefix":"10.1016","volume":"11","author":[{"given":"E. Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1994","series-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","key":"10.1016\/j.jocd.2008.07.003_bib1"},{"issue":"7041","key":"10.1016\/j.jocd.2008.07.003_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jocd.2008.07.003_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocd.2007.12.007","article-title":"Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 position development conference","volume":"11","author":"Baim","year":"2008","journal-title":"J\u00a0Clin Densitom"},{"year":"2003","series-title":"Physician's guide to prevention and treatment of osteoporosis","author":"National Osteoporosis Foundation","key":"10.1016\/j.jocd.2008.07.003_bib4"},{"issue":"12","key":"10.1016\/j.jocd.2008.07.003_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2008.07.003_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral fractures but not wrist fractures","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2008.07.003_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jocd.2008.07.003_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1566524023362104","article-title":"Bisphosphonate mechanism of action","volume":"2","author":"Rodan","year":"2002","journal-title":"Curr Mol Med"},{"year":"2004","series-title":"Bone health and osteoporosis: a report of the surgeon general","author":"US Department of Health and Human Services","key":"10.1016\/j.jocd.2008.07.003_bib9"},{"issue":"6","key":"10.1016\/j.jocd.2008.07.003_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00198-006-0310-z","article-title":"Fracture risk and antiresorptive medication use in older women in the USA","volume":"18","author":"Gehlbach","year":"2007","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jocd.2008.07.003_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s00198-003-1492-2","article-title":"The management of osteoporosis following hip fracture: have we improved our care?","volume":"14","author":"Bahl","year":"2003","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2008.07.003_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1525-1497.2006.00395.x","article-title":"Incidental vertebral fractures on chest radiographs. Recognition, documentation, and treatment","volume":"21","author":"Morris","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"12","key":"10.1016\/j.jocd.2008.07.003_bib13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0025-6196(11)61093-8","article-title":"Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis","volume":"82","author":"Kothawala","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.jocd.2008.07.003_bib14","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2105\/AJPH.94.10.1782","article-title":"Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk","volume":"94","author":"Piette","year":"2004","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.jocd.2008.07.003_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dkf046","article-title":"Patient compliance with antibiotic treatment for respiratory tract infections","volume":"49","author":"Kardas","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"8714","key":"10.1016\/j.jocd.2008.07.003_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0140-6736(90)92095-Y","article-title":"Treatment adherence and risk of death after a myocardial infarction","volume":"336","author":"Horwitz","year":"1990","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jocd.2008.07.003_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","article-title":"Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women","volume":"80","author":"Recker","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.jocd.2008.07.003_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","article-title":"A systematic review of persistence and compliance with bisphosphonates for osteoporosis","volume":"18","author":"Cramer","year":"2007","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jocd.2008.07.003_bib19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.smj.0000221637.90495.66","article-title":"Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting","volume":"99","author":"Downey","year":"2006","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.jocd.2008.07.003_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jocd.2008.07.003_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.jocd.2008.07.003_bib22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/SMJ.0b013e31815a96de","article-title":"Medications don't work if patients don't take them","volume":"100","author":"Lewiecki","year":"2007","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.jocd.2008.07.003_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinthera.2006.01.002","article-title":"Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis","volume":"28","author":"Penning-van Beest","year":"2006","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.jocd.2008.07.003_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1742-1241.2006.01059.x","article-title":"Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study","volume":"60","author":"Cooper","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"4 Suppl 1","key":"10.1016\/j.jocd.2008.07.003_bib25","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.bone.2006.01.150","article-title":"Adherence, patient preference and dosing frequency: understanding the relationship","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.jocd.2008.07.003_bib26","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0149-2918(02)80085-6","article-title":"Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study","volume":"24","author":"Simon","year":"2002","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.jocd.2008.07.003_bib27","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/art.21918","article-title":"Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study","volume":"54","author":"Delmas","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jocd.2008.07.003_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jocd.2008.07.003_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2710.2004.00584.x","article-title":"Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis","volume":"29","author":"Cauza","year":"2004","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.jocd.2008.07.003_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.rhu.0000152141.47663.e4","article-title":"Comparison of intravenous pamidronate to standard therapy for osteoporosis: use in patients unable to take oral bisphosphonates","volume":"11","author":"Miller","year":"2005","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.jocd.2008.07.003_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"18","key":"10.1016\/j.jocd.2008.07.003_bib32","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jocd.2008.07.003_bib33","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"18","key":"10.1016\/j.jocd.2008.07.003_bib34","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"year":"2008","series-title":"Clinician's guide to prevention and treatment of osteoporosis","author":"National Osteoporosis Foundation","key":"10.1016\/j.jocd.2008.07.003_bib35"},{"issue":"3","key":"10.1016\/j.jocd.2008.07.003_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","article-title":"Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis","volume":"148","author":"MacLean","year":"2008","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jocd.2008.07.003_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","article-title":"An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates","volume":"61","author":"Thiebaud","year":"1997","journal-title":"Calcif Tissue Int"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695008002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695008002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:35:24Z","timestamp":1761082524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695008002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1094695008002114"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2008.07.003","relation":{},"ISSN":["1094-6950"],"issn-type":[{"type":"print","value":"1094-6950"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Clinician's Perspective on the Use of Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2008.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}